Related Experiment Video
Updated: Apr 30, 2026

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
Cancer Research in the Age of Spatial Omics: Lessons from IMAXT
Dario Bressan1, , Nicholas Walton2
1CRUK Cambridge Institute, University of Cambridge. Li Ka Shing Centre, Cambridge, United Kingdom.
This research pioneers 3D molecularly annotated tumor maps using advanced single-cell and spatial omics. These tools are revolutionizing cancer research by detailing tumor heterogeneity and micro-environments.
Area of Science:
- Oncology
- Genomics
- Biotechnology
Background:
- Cancer research traditionally relies on 2D pathology, limiting understanding of complex tumor structures.
- Tumor heterogeneity and the tumor micro-environment are critical factors in cancer progression and treatment resistance.
- Emerging omics technologies offer new avenues for detailed biological investigation.
Purpose of the Study:
- To develop next-generation pathology and cancer research tools.
- To create 3D molecularly annotated maps of tumors.
- To investigate the roles of tumor heterogeneity and the tumor micro-environment.
Main Methods:
- Utilizing a combination of single-cell and spatial omics tools.
- Developing advanced imaging and molecular annotation techniques.
- Integrating multi-omic data for comprehensive tumor profiling.
Main Results:
- The team's activities catalyzed a spatial revolution in biology.
- New technologies were deployed to study tumors.
- Progress was made towards creating 3D molecularly annotated tumor maps.
Conclusions:
- The integration of single-cell and spatial omics is transforming cancer research.
- Understanding tumor heterogeneity and micro-environments is crucial for future cancer therapies.
- This approach provides a foundation for next-generation cancer diagnostics and treatments.
Related Concept Videos
Genomics
Cancers Originate from Somatic Mutations in a Single Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

